17-Hydroxysteroid dehydrogenase from the filamentous fungus Cochliobolus lunatus (17-HSDcl) is an NADP(H)-dependent enzyme that preferentially catalyses the oxidoreduction of oestrogens and androgens. The enzyme belongs to the short-chain dehydrogenase/reductase superfamily and is the only fungal hydroxysteroid dehydrogenase known to date. 17-HSDcl has recently been characterized and cloned and has been the subject of several functional studies. Although several hypotheses on the physiological role of 17-HSDcl in fungal metabolism have been formulated, its function is still unclear. An X-ray crystallographic study has been undertaken and the optimal conditions for crystallization of 17-HSDcl (apo form) were established, resulting in well shaped crystals that diffracted to 1.7 Å resolution. The space group was identified as I4 1 22, with unit-cell parameters a = b = 67.14, c = 266.77 Å . Phasing was successfully performed by Patterson search techniques. A catalytic inactive mutant Tyr167Phe was also engineered, expressed, purified and crystallized for functional and structural studies.
Introduction
Hydroxysteroid dehydrogenases (HSDs) are enzymes that are essential for the biosynthesis of hormonally active steroids and that are responsible for their pre-receptor action regulation (Penning, 1997 (Penning, , 2003 . 17-Hydroxysteroid dehydrogenase (17-HSD) modulates the biological potency of androgens and oestrogens by converting the inactive 17-keto steroids into their active 17-hydroxy forms or vice versa (Mindnich et al., 2004) . To date, 12 different types of 17-HSD have been described that differ in their localization and enzymatic behaviour (Mindnich et al., 2004) ; they have been found in primitive microorganisms such as bacteria, yeast and fungi, as well as in all vertebrates. Moreover, several 17-HSD human types have been related to the development of pathologies (Mindnich et al., 2004) such as pseudo-hermaphroditism, polycystic kidney disease and Alzheimer's disease and various hormone-dependent types of cancer.
17-HSDs belong to one of two protein superfamilies: the shortchain dehydrogenase/reductases (SDRs) or the aldo-ketoreductases (AKRs). Enzymes belonging to the SDR superfamily (Kallberg et al., 2002) show a large sequence divergence, but share some common characteristics: they have a molecular mass in the range 25-35 kDa, they are non-metalloenzymes, they are functional as oligomers (dimers or tetramers) and they require NAD(P)(H) as a cofactor. Several sequence motifs are conserved among all members of the superfamily and despite the low level (15-30%) of amino-acid sequence identity, structural studies have shown that SDR members share a remarkable folding similiarity.
17-Hydroxysteroid dehydrogenase from the filamentous fungus Cochliobolus lunatus (17-HSDcl) is an NADP(H)-dependent enzyme that preferentially catalyses the oxidoreduction of oestrogens and androgens (Lanišnik Rižner et al., 1999) . It is the only fungal HSD that has been cloned and purified to date (Lanišnik Rižner et al., 1999) . The 17-HSDcl sequence contains the characteristic signature motifs of the SDR superfamily: a TGXXXGXG pattern found at the N-terminus as part of the dinucleotide-binding site and a YXXXK pattern as part of the active site (Kallberg et al., 2002; Lanišnik Rižner et al., 1999) . 17-HSDcl possesses a high percentage of sequence identity to fungal carbonyl reductases involved in the biosynthesis of aflatoxins and the fungal pigment melanin, including versicolorin reductase from Aspergillus parasiticus (67%), versicolorin reductase from Emericella nidulans (65%), 1,3,8-trihydroxynaphtalene reductase (3HNR) from Colletotrichum lagenarium (61%) and Magnaporthe grisea (58%) and tetrahydroxynaphtalene reductase (4HNR) from M. grisea (51%). To a lesser extent, 17-HSDcl also shares sequence similarity to Escherichia coli 7-HSD (37%) and to human 17-HSD types 4 and 8 (31%) (Lanišnik Rižner et al., 1999) .
It is worthy of note that 17-HSDcl differs from fungal carbonyl reductases and does not convert 2,3-dihydro-2,5-dihydroxy-4Hbenzopyran-4-one (DDBO), an artificial substrate of several fungal 3HNRs and 4HNRs, to 4,5-dihydroxy-2H-benzopyran-2-one (DBO) (Thompson et al., 1997 (Thompson et al., , 1998 . Furthermore, tricyclazole, a specific inhibitor of 3HNR and 4HNR, does not inhibit 17-HSDcl (Lanišnik Rižner et al., 2001) . We have recently identified the 3HNR gene in Cochliobolus lunatus and reported its cloning, heterologous expression, protein purification and biochemical characterization (Lanišnik Rižner & Wheeler, 2003) . This enzyme converts DDBO and, to a lesser extent, scytalone, the natural substrate of 4HNR, to 1,3,8trihydroxynaphatalene (Lanišnik Rižner & Wheeler, 2003) . These results are consistent with the findings of Thompson et al. (1998) , who reported that 3HNR from M. grisea oxidizes DDBO to DBO much more readily than it does scytalone to 1,3,6,8-tetrahydroxynaphthalene (Thompson et al., 1997 (Thompson et al., , 1998 . Thus, in spite of the high sequence similarity, 17-HSDcl is not a 3HNR or 4HNR and its specificity towards steroids makes the elucidation of its physiological role intriguing. On the basis of sequence homology and structural similarity, several possible functional implications have been considered for 17-HSDcl (Lanišnik Rižner et al., 2001) : participation in the biosynthesis of mycotoxins, involvement in the melaninbiosynthetic pathway, a possible role in fungal steroid signalling and possible participation in a fungal detoxification system.
A structure-based homology model of 17-HSDcl with the docked cofactor NADPH and the substrate androstenedione has already been proposed (Lanišnik Rižner et al., 2000) . In order to validate the homology-built model and to gain further insights into the structure and function of this model enzyme, we have initiated the production and purification of the wild-type 17-HSDcl enzyme on a multimilligram scale in order to determine its X-ray structure. Moreover, its very high similarity to SDR members with unknown threedimensional structures, such as fungal carbonyl reductases and human 17-HSD type 8, allows 17-HSDcl to be exploited as an alternative model enzyme of the SDR superfamily.
Methods and results
2.1. Cloning, overexpression and purification of 17b-HSDcl
The protein-coding sequence of 17HSDcl was cloned into the pGEX expression vector as a fusion protein with GST at its N-terminus (Lanišnik Rižner et al., 1999) . The recombinant fusion protein GST-17-HSDcl was expressed in E. coli strain JM107, purified to homogeneity by affinity chromatography on glutathione Sepharose and recovered, after thrombin cleavage, as recombinant 17-HSDcl (Lanišnik Rižner et al., 1999) . The yield of production was approximately 5 mg of protein per litre of bacterial culture. The recombinant protein was about 95% homogenous as assessed by SDS-PAGE: the samples (10 or 15 mg) were denatured in Laemmli sample buffer (5 min at 363 K) and then applied onto the gel (12 or 15% acrylamide). Proteins were visualized by Coomassie blue staining.
The 17-HSDcl enzyme preparation was not contaminated with GST; GST-specific antibodies recognized only purified GST and GST-17-HSDcl fusion protein, but not purified 17-HSDcl.
Recombinant 17-HSDcl, at concentrations ranging from 1.5 to 2.5 mg ml À1 , was kept in PBS buffer pH 7.3 and stored at 193 K. For crystallization trials, the enzyme was concentrated to 10-20 mg ml À1 by ultrafiltration through YM membrane at 4000g at 277 K using Centricon 10 concentrators (Amicon, USA).
The 17-HSD Tyr167Phe mutant was generated by the Quick ChangeQ site-directed mutagenesis kit (Stratagene). The forward primer 5 0 CCA AAG CAC TCG CTG TTC TCT GGG TCC AAG GGC G 3 0 and the reverse primer 5 0 CGC CCT TGG ACC CAG AGA ACA GCG AGT GCT TTG G 3 0 were hybridized to template DNA consisting of the construct pGEX-17-HSDcl. Mutagenesis reactions followed the standard protocol described by Stratagene. The designed mutation was verified by DNA sequencing. The Tyr167Phe mutant was expressed in E. coli as previously described for wild-type 17-HSD. Well shaped bipyramidal diffraction-quality crystals of wild-type 17-HSDcl (apo form). Table 1 Crystal parameters, data-collection and processing statistics for the apo form and the Tyr167Phe mutant of 17-HSDcl.
Values in parentheses are for the highest resolution shell.
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Crystallization
Initial crystallization trials of 17-HSDcl (apo form) were based on the sparse-matrix sampling approach (Jancarik & Kim, 1991) using the hanging-drop vapour-diffusion method, exploring variations in temperature (294 and 277 K) and pH (5-9) and using PEG 6000 as the precipitant in the range 10-30% (w/v) as described for the crystallization of 3HNR from M. grisea (Andersson, Jordan, Schneider, Valent et al., 1996; Andersson et al., 1997; Liao et al., 2001) . The most promising lead condition was found to be 0.1 M Tris pH 8.0, 20% PEG 6000. Unfortunately, analysis of the diffraction patterns of several crystals revealed them to be poorly diffracting and highly mosaic. Diffraction quality and well shaped bipyramidal crystals were eventually obtained under optimized conditions at 277 K by mixing equal volumes (2 ml) of reservoir solution [0.1 M Tris pH 8.0, 20%(w/v) PEG 6000 and 20%(v/v) glycerol] and protein stock solution (10-20 mg ml À1 in 50 mM Tris-HCl pH 7.0, 105 mM NaCl). Typical 17-HSDcl crystals are shown in Fig. 1 ; they reached maximum dimensions over a period of 30-40 d. The same crystallization conditions were applied to the Tyr167Phe mutant of 17-HSDcl, except that the protein concentration was 7.3 mg ml À1 in 50 mM Tris-HCl pH 7.0, 105 mM NaCl. Crystals grew over 3-7 d, showing the same morphology as observed for the native enzyme but with consistently smaller dimensions (see Table 1 ).
Data collection, processing and structure solution
A complete data set at 1.7 Å resolution was collected from a native 17-HSDcl crystal at beamline XRD-1 (Bernstorff et al., 1995) of the Italian synchrotron facility ELETTRA (Trieste, Italy) using a MAR345 imaging-plate detector (MAR Research, Germany). The crystal was directly flash-cooled in a stream of cold nitrogen gas at 100 K using an Oxford Cryosystems cooling device (Oxford Cryosystems Ltd, UK). There was no need for prior crystal transfer to a cryoprotecting solution. X-ray diffraction images were indexed, integrated and subsequently scaled using the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997) ; the CCP4 package (Collaborative Computational Project, Number 4, 1994) was used for data reduction. Crystal and data-collection statistics are summarized in Table 1 .
The structure of 17-HSDcl was determined by Patterson search techniques (data to 3.5 Å ) using the monomer of 3HNR (PDB code 1g0n; Liao et al., 2001 ) as a search model (58% amino-acid sequence identity) after removal of all solvent, cofactor and inhibitor molecules. A unique solution for 17-HSDcl was obtained only when assuming the space group to be I4 1 22. A final correlation coefficient of 0.68 and an R factor of 0.35 were obtained using the AMoRe package (Navaza, 2001) . Graphical inspection of the crystal packing with the program O (Jones et al., 1991) confirmed the correctness of the solution. Data collection, processing and phasing of the Tyr167Phe mutant were the same as for the native 17-HSDcl. The coordinates of the partial refined structure of the native 17-HSDcl were then used as a search model, which resulted in a final correlation coefficient of 0.76 and an R factor of 0.32. Model rebuilding and further refinement are under way for both crystal structures.
The crystallization and structure determination of the 17-HSDcl Tyr167Phe mutant in complex with a variety of substrates and substrate analogues will also be attempted, leading to a structurebased elucidation of the enzyme mechanism of action and of its substrate-binding specificities.
